The Next-Generation Sequencing (NGS) market is booming, projected to reach $9.11 billion by 2033 with a 7.7% CAGR. Driven by personalized medicine, drug discovery, and technological advancements, this report analyzes market size, key players (Illumina, Thermo Fisher), and regional trends in NGS. Discover the future of genomics!
We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.
